Literature DB >> 12604601

The vesicular monoamine content regulates VMAT2 activity through Galphaq in mouse platelets. Evidence for autoregulation of vesicular transmitter uptake.

Markus Höltje1, Sandra Winter, Diego Walther, Ingrid Pahner, Heide Hörtnagl, Ole Petter Ottersen, Michael Bader, Gudrun Ahnert-Hilger.   

Abstract

Variations in the neurotransmitter content of secretory vesicles enable neurons to adapt to network changes. Vesicular content may be modulated by vesicle-associated Go(2), which down-regulates the activity of the vesicular monoamine transmitter transporters VMAT1 in neuroendocrine cells and VMAT2 in neurons. Blood platelets resemble serotonergic neurons with respect to transmitter storage and release. In streptolysin O-permeabilized platelets, VMAT2 activity is also down-regulated by the G protein activator guanosine 5'-(beta(i)gamma-imido)triphosphate (GMppNp). Using serotonin-depleted platelets from peripheral tryptophan hydroxylase knockout (Tph1-/-) mice, we show here that the vesicular filling initiates the G protein-mediated down-regulation of VMAT2 activity. GMppNp did not influence VMAT2 activity in naive platelets from Tph1-/- mice. GMppNp-mediated inhibition could be reconstituted, however, when preloading Tph1-/- platelets with serotonin or noradrenaline. Galpha(q) mediates the down-regulation of VMAT2 activity as revealed from uptake studies performed with platelets from Galpha(q) deletion mutants. Serotonergic, noradrenergic, as well as thromboxane A(2) receptors are not directly involved in the down-regulation of VMAT2 activity. It is concluded that in platelets the vesicle itself regulates transmitter transporter activity via its content and vesicle-associated Galpha(q).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12604601     DOI: 10.1074/jbc.M212816200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

Review 1.  Vesicular and plasma membrane transporters for neurotransmitters.

Authors:  Randy D Blakely; Robert H Edwards
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-02-01       Impact factor: 10.005

Review 2.  The vesicular monoamine transporter 2: an underexplored pharmacological target.

Authors:  Alison I Bernstein; Kristen A Stout; Gary W Miller
Journal:  Neurochem Int       Date:  2014-01-04       Impact factor: 3.921

3.  Severe serotonin depletion after conditional deletion of the vesicular monoamine transporter 2 gene in serotonin neurons: neural and behavioral consequences.

Authors:  Nicolas Narboux-Nême; Corinne Sagné; Stephane Doly; Silvina L Diaz; Cédric B P Martin; Gaelle Angenard; Marie-Pascale Martres; Bruno Giros; Michel Hamon; Laurence Lanfumey; Patricia Gaspar; Raymond Mongeau
Journal:  Neuropsychopharmacology       Date:  2011-08-03       Impact factor: 7.853

4.  Evidence for defective mesolimbic dopamine exocytosis in obesity-prone rats.

Authors:  Brenda M Geiger; Gerald G Behr; Lauren E Frank; Angela D Caldera-Siu; Margery C Beinfeld; Efi G Kokkotou; Emmanuel N Pothos
Journal:  FASEB J       Date:  2008-05-13       Impact factor: 5.191

Review 5.  Storage pool diseases illuminate platelet dense granule biogenesis.

Authors:  Andrea L Ambrosio; Santiago M Di Pietro
Journal:  Platelets       Date:  2016-11-16       Impact factor: 3.862

6.  Elevated platelet vesicular monoamine transporter 2 in former heroin addicts maintained on methadone.

Authors:  K Schwartz; I Herman; G Peer; A Weizman; M Rehavi
Journal:  J Neural Transm (Vienna)       Date:  2006-07-20       Impact factor: 3.575

7.  Platelet dense granules begin to selectively accumulate mepacrine during proplatelet formation.

Authors:  Hayley A Hanby; Jialing Bao; Ji-Yoon Noh; Danuta Jarocha; Mortimer Poncz; Mitchell J Weiss; Michael S Marks
Journal:  Blood Adv       Date:  2017-08-22

8.  Development of antithrombotic miniribozymes that target peripheral tryptophan hydroxylase.

Authors:  Jens-Uwe Peter; Natalia Alenina; Michael Bader; Diego J Walther
Journal:  Mol Cell Biochem       Date:  2006-08-22       Impact factor: 3.396

9.  Electrochemical measurement of endogenous serotonin release from human blood platelets.

Authors:  Shencheng Ge; Emily Woo; James G White; Christy L Haynes
Journal:  Anal Chem       Date:  2011-03-08       Impact factor: 6.986

10.  Mechanism of platelet dense granule biogenesis: study of cargo transport and function of Rab32 and Rab38 in a model system.

Authors:  Andrea L Ambrosio; Judith A Boyle; Santiago M Di Pietro
Journal:  Blood       Date:  2012-08-27       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.